MKI67 and neuroendocrine carcinoma: Furthermore, according to the World Health Organization (WHO) classification 2019, it is classified as NET G1, G2, G3, and NEC G3 based on Ki-67, which is a proliferation marker that reflects prognosis (Table 1).